Elliptic Laboratories ASA
OSE:ELABS.OL
17.56 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 131.914 | 68.321 | 52.062 | 54.598 | 30.215 | 37.957 | 41.581 | 10.695 |
| Cost of Revenue
| 87.861 | 80.552 | 62.802 | 50.807 | 35.866 | 45.651 | 46.965 | 41.204 |
| Gross Profit
| 44.053 | -12.231 | -10.74 | 3.791 | -5.651 | -7.694 | -5.384 | -30.509 |
| Gross Profit Ratio
| 0.334 | -0.179 | -0.206 | 0.069 | -0.187 | -0.203 | -0.129 | -2.853 |
| Reseach & Development Expenses
| 0 | 21.287 | 8.141 | 5.703 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5.692 | 8.079 | 5.975 | 5.591 | 5.59 | 5.159 | 4.123 | 0 |
| Selling & Marketing Expenses
| 6.919 | 8.717 | 5.385 | 4.75 | 3.734 | 6.341 | 7.681 | 4.585 |
| SG&A
| 12.611 | 16.796 | 11.36 | 10.341 | 9.323 | 11.5 | 11.804 | 4.585 |
| Other Expenses
| 26.732 | 0 | 20.031 | 4.59 | -4.873 | -6.201 | 15.385 | 7.816 |
| Operating Expenses
| 39.343 | 37.512 | 31.391 | 14.931 | 4.451 | 5.298 | 27.189 | 12.401 |
| Operating Income
| 4.71 | -49.743 | -42.131 | -11.14 | -10.102 | -12.992 | -32.573 | -42.91 |
| Operating Income Ratio
| 0.036 | -0.728 | -0.809 | -0.204 | -0.334 | -0.342 | -0.783 | -4.012 |
| Total Other Income Expenses Net
| 12.337 | 2.886 | 2.829 | -1.952 | -5.455 | -3.968 | -0.663 | -0.57 |
| Income Before Tax
| 17.047 | -46.857 | -39.302 | -13.092 | -15.557 | -16.96 | -33.236 | -43.48 |
| Income Before Tax Ratio
| 0.129 | -0.686 | -0.755 | -0.24 | -0.515 | -0.447 | -0.799 | -4.066 |
| Income Tax Expense
| 8.086 | -8.856 | -6.303 | -1.878 | -3.047 | -3.703 | -5.116 | -9.231 |
| Net Income
| 8.96 | -38.001 | -32.999 | -11.214 | -12.51 | -13.257 | -28.121 | -34.249 |
| Net Income Ratio
| 0.068 | -0.556 | -0.634 | -0.205 | -0.414 | -0.349 | -0.676 | -3.202 |
| EPS
| 0.082 | -0.36 | -0.32 | -0.11 | -0.14 | -0.13 | -0.29 | -0.36 |
| EPS Diluted
| 0.079 | -0.36 | -0.32 | -0.11 | -0.14 | -0.13 | -0.29 | -0.36 |
| EBITDA
| 42.078 | -39.792 | -33.43 | -9.031 | -10.019 | -9.817 | -28.774 | -40.484 |
| EBITDA Ratio
| 0.319 | -0.582 | -0.514 | -0.066 | -0.245 | -0.259 | -0.706 | -3.785 |